Research Briefing | Apr 20, 2021

US | Green shoots of recovery emerge with vaccine rollout

Green shoots of recovery emerge with vaccine rollout - iPad

The next stage of the US travel recovery has commenced. After a challenging fall and winter, signals are turning positive. Travel activity picked up in March, with spring break leisure travel a key contributor, and forward-looking booking activity has quickened, with gains in hotel bookings and air travel. The improvement represents the first substantive gains since the easing of lockdown protocols last year (May/June 2020).

What you will learn:

  • Travel sentiment has been steadily increasing in lockstep with the expansion of the vaccine rollout.
  • Improving health conditions, expanding vaccine distribution, and generous fiscal stimulus together support the trajectory of economic recovery, with our outlook for GDP growth in 2021 recently raised to 7%.
  • Our current outlook is for travel spending in the US to recover to just 20% below 2019 levels this year.
Tags: CoronavirusCoronavirus vaccineNorth AmericaRecoveryTourismTourism recoveryTravelUnited StatesVaccine rollout
Back to Resource Hub

Related Services

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

Takaichi’s big win doesn’t affect the fiscal outlook for Japan

The ruling Liberal Democratic Party's (LDP) landslide election victory on Sunday doesn't change our expectation of a primary fiscal deficit of 2%-3% of GDP in FY2026-FY2028 – we still see the deficit only starting to decline from FY2029. We also keep our view that the 10-year Japanese government bond (JGB) yield will be at 2.3% at end-2026 and 2.5% at end-2027 and beyond.
US and Chinese strength won’t boost all other economies

US and Chinese strength won’t boost all other economies

Upward revisions to US and Chinese GDP growth in Q4 meant that the previously anticipated soft end to 2025 failed to materialise.